CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
PureKana›
Library
PureKana logo

PureKana

PureKana: Your trusted provider of diverse CBD-based wellness products.

Scottsdale, AZ, US🇺🇸
Founded
2017
Loading
Overview
Compare
Fundraising
Employees
Library

PureKana - Library

purekana.com·Crawled Oct 16, 2026·

Topics

Publication type

Content origin
Row density

Product

6 pages
  1. 100mg Extra Strength DELTA gummies/products/thc-p-gummies-2000mg

    PureKana’s 100 mg Extra Strength Gummies contain 87 mg Delta-8, 12 mg Delta-9, and 1 mg THC-P.

  2. 500 mg CBD oil for pets/products/cbd-oil-for-pets-500mg

    Pure Kana offers 500 mg bacon-flavored CBD oil for pets.

  3. 600 mg CBD oil/products/cbd-oil-600mg-full-spectrum-tincture-subscribers

    PureKana’s 600mg CBD oil for sale now comes in five delicious flavors: Mint, Natural, Vanilla and Citrus.

  4. CBD dog treats for mobility and anxiety/products/cbd-dog-treats-for-anxiety

    PureKana offers 150 mg CBD dog treats in two formulations intended to support mobility and anxiety.

Blog

6 pages
  1. CBD Facts vs. Myths: Breaking it All Down!/blogs/cbd-education/find-out-cbd-facts-vs-myths

    The page discusses common myths about CBD, describing it as non-intoxicating and noting its potential wellness properties.

  2. CBD Isolate vs Full Spectrum CBD: What’s the Difference?/blogs/news/cbd-isolate-vs-full-spectrum-cbd-whats-the-difference

    The page compares CBD isolate and full-spectrum CBD, noting that each has distinct pros and cons.

  3. CBD isolate vs. Full-spectrum oil/blogs/cbd-education/cbd-isolate-vs-full-spectrum-cbd-oil

    PureKana explains that CBD isolate oil contains only CBD extract and compares it with full-spectrum CBD oil.

  4. CBN vs. CBD: How They Affect Your Body Differently/blogs/cbd-education/cbn-vs-cbd

    The company says hemp contains hundreds of cannabinoids, identifies CBD and THC as common cannabinoids, and announces a new line of CBN edible gummies.

Homepage

1 page
  1. Homepage/